• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西国家免疫规划中常规婴儿免疫接种的脊髓灰质炎灭活疫苗-口服脊髓灰质炎疫苗序贯接种程序介绍。

Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.

作者信息

Domingues Carla Magda Allan S, de Fátima Pereira Sirlene, Cunha Marreiros Ana Carolina, Menezes Nair, Flannery Brendan

机构信息

Secretariat of Health Surveillance, Brazilian Ministry of Health Center for Tropical Medicine, University of Brasília, Distrito Federal, Brazil.

Secretariat of Health Surveillance, Brazilian Ministry of Health.

出版信息

J Infect Dis. 2014 Nov 1;210 Suppl 1(0 1):S143-51. doi: 10.1093/infdis/jit588.

DOI:10.1093/infdis/jit588
PMID:25316829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4758462/
Abstract

In August 2012, the Brazilian Ministry of Health introduced inactivated polio vaccine (IPV) as part of sequential polio vaccination schedule for all infants beginning their primary vaccination series. The revised childhood immunization schedule included 2 doses of IPV at 2 and 4 months of age followed by 2 doses of oral polio vaccine (OPV) at 6 and 15 months of age. One annual national polio immunization day was maintained to provide OPV to all children aged 6 to 59 months. The decision to introduce IPV was based on preventing rare cases of vaccine-associated paralytic polio, financially sustaining IPV introduction, ensuring equitable access to IPV, and preparing for future OPV cessation following global eradication. Introducing IPV during a national multivaccination campaign led to rapid uptake, despite challenges with local vaccine supply due to high wastage rates. Continuous monitoring is required to achieve high coverage with the sequential polio vaccine schedule.

摘要

2012年8月,巴西卫生部引入了灭活脊髓灰质炎疫苗(IPV),作为所有开始初次疫苗接种系列的婴儿脊髓灰质炎序贯疫苗接种计划的一部分。修订后的儿童免疫接种计划包括在2个月和4个月大时接种2剂IPV,随后在6个月和15个月大时接种2剂口服脊髓灰质炎疫苗(OPV)。保留了一个年度全国脊髓灰质炎免疫日,为所有6至59个月大的儿童提供OPV。引入IPV的决定基于预防罕见的疫苗相关麻痹性脊髓灰质炎病例、在经济上支持IPV的引入、确保公平获得IPV以及为全球根除脊髓灰质炎后未来停止使用OPV做准备。尽管由于高浪费率导致当地疫苗供应面临挑战,但在全国多疫苗接种运动期间引入IPV仍导致了快速采用。需要持续监测以实现脊髓灰质炎序贯疫苗接种计划的高覆盖率。

相似文献

1
Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.巴西国家免疫规划中常规婴儿免疫接种的脊髓灰质炎灭活疫苗-口服脊髓灰质炎疫苗序贯接种程序介绍。
J Infect Dis. 2014 Nov 1;210 Suppl 1(0 1):S143-51. doi: 10.1093/infdis/jit588.
2
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).美国的脊髓灰质炎预防:采用先接种灭活脊髓灰质炎病毒疫苗后接种口服脊髓灰质炎病毒疫苗的序贯接种程序。免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.
3
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.用于预防脊髓灰质炎的序贯灭活脊髓灰质炎疫苗(IPV)和口服脊髓灰质炎减毒活疫苗(OPV)
Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2.
4
Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010-2014.引入灭活脊髓灰质炎疫苗以推进脊髓灰质炎根除终局战略计划;中国杭州,2010 - 2014年
Vaccine. 2017 Mar 1;35(9):1281-1286. doi: 10.1016/j.vaccine.2017.01.034. Epub 2017 Feb 1.
5
Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.脊髓灰质炎疫苗。全球根除脊髓灰质炎的进展以及美国常规免疫接种建议的变化。
Pediatr Clin North Am. 2000 Apr;47(2):287-308. doi: 10.1016/s0031-3955(05)70208-x.
6
Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.印度脊髓灰质炎免疫策略的预算影响:引入一剂灭活脊髓灰质炎疫苗和减少补充脊髓灰质炎免疫。
Public Health. 2017 Jan;142:31-38. doi: 10.1016/j.puhe.2016.10.016. Epub 2016 Nov 17.
7
Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis - Beijing, China, 2014-2016.灭活脊髓灰质炎疫苗的引入及其对疫苗相关麻痹型脊髓灰质炎的影响——中国北京,2014 - 2016年
MMWR Morb Mortal Wkly Rep. 2017 Dec 15;66(49):1357-1361. doi: 10.15585/mmwr.mm6649a4.
8
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.1991年至1998年脊髓灰质炎疫苗不良事件监测:灭活脊髓灰质炎疫苗随后接种口服脊髓灰质炎疫苗的序贯接种方案的影响
Pediatrics. 2001 May;107(5):E83. doi: 10.1542/peds.107.5.e83.
9
Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.脊髓灰质炎病毒免疫获得的监测,包括用萨宾株来源的灭活疫苗进行免疫接种。
Hum Vaccin Immunother. 2019;15(5):1154-1159. doi: 10.1080/21645515.2019.1572408. Epub 2019 Mar 11.
10
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.在智利婴儿中单独使用或与二价口服脊髓灰质炎疫苗序贯使用灭活脊髓灰质炎病毒疫苗:一项随机、对照、开放性标签、四期、非劣效性研究。
Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26.

引用本文的文献

1
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.疫苗的药物警戒:重要性、主要方面、前景与挑战——一篇叙述性综述
Pharmaceuticals (Basel). 2024 Jun 19;17(6):807. doi: 10.3390/ph17060807.
2
Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China.中国杭州不同灭活脊灰疫苗免疫程序的成本效果分析。
Front Public Health. 2022 Sep 23;10:990042. doi: 10.3389/fpubh.2022.990042. eCollection 2022.
3
Cost-Effectiveness of Three Poliovirus Immunization Schedules in Shanghai, China.中国上海三种脊髓灰质炎病毒免疫接种方案的成本效益
Vaccines (Basel). 2021 Sep 23;9(10):1062. doi: 10.3390/vaccines9101062.
4
National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.国家决策引进新疫苗:系统评价,2010-2020 年。
Vaccine. 2021 Apr 1;39(14):1897-1909. doi: 10.1016/j.vaccine.2021.02.059. Epub 2021 Mar 6.
5
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.用于预防脊髓灰质炎的序贯灭活脊髓灰质炎疫苗(IPV)和口服脊髓灰质炎减毒活疫苗(OPV)
Cochrane Database Syst Rev. 2019 Dec 5;12(12):CD011260. doi: 10.1002/14651858.CD011260.pub2.
6
Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.原发性免疫缺陷病患者定期接受静脉注射免疫球蛋白治疗后,其脊髓灰质炎病毒抗体水平较低。
J Clin Immunol. 2018 Jul;38(5):628-634. doi: 10.1007/s10875-018-0531-x. Epub 2018 Jul 14.
7
Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame.从管理灭活脊髓灰质炎疫苗引进的规划与实施中汲取的经验教训,以支持脊髓灰质炎根除行动。
J Infect Dis. 2017 Jul 1;216(suppl_1):S15-S23. doi: 10.1093/infdis/jix185.
8
Administering Multiple Injectable Vaccines During a Single Visit-Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally.在单次就诊时接种多种注射用疫苗——全球加速引入灭活脊髓灰质炎疫苗的研究结果总结
J Infect Dis. 2017 Jul 1;216(suppl_1):S152-S160. doi: 10.1093/infdis/jix054.
9
Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April-November 2015.2015年4月至11月对尼日利亚卡诺州灭活脊髓灰质炎疫苗的引进与使用情况进行评估
J Infect Dis. 2017 Jul 1;216(suppl_1):S137-S145. doi: 10.1093/infdis/jix044.
10
Acute flaccid paralysis laboratorial surveillance in a polio-free country: Brazil, 2005-2014.无脊髓灰质炎国家的急性弛缓性麻痹实验室监测:巴西,2005 - 2014年
Hum Vaccin Immunother. 2017 Mar 4;13(3):717-723. doi: 10.1080/21645515.2016.1236164. Epub 2016 Nov 30.

本文引用的文献

1
Poliovirus vaccination options for achieving eradication and securing the endgame.脊灰病毒疫苗接种选项,以实现根除并确保终局之战。
Curr Opin Virol. 2013 Jun;3(3):309-15. doi: 10.1016/j.coviro.2013.05.007. Epub 2013 Jun 10.
2
Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 – conclusions and recommendations.免疫战略咨询专家组会议,2012年11月——结论与建议
Wkly Epidemiol Rec. 2013 Jan 4;88(1):1-16.
3
National immunization program: vaccination, compliance and pharmacovigilance.国家免疫规划:疫苗接种、依从性与药物警戒
Rev Inst Med Trop Sao Paulo. 2012 Oct;54 Suppl 18:S22-7. doi: 10.1590/s0036-46652012000700009.
4
Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa.将灭活脊髓灰质炎疫苗(IPV)纳入南非常规免疫计划。
Vaccine. 2012 Sep 7;30 Suppl 3:C35-7. doi: 10.1016/j.vaccine.2012.02.056.
5
Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007-2008.社会经济不平等与疫苗接种覆盖率:27 个巴西首府 2007-2008 年免疫接种覆盖率调查结果。
J Epidemiol Community Health. 2012 Oct;66(10):934-41. doi: 10.1136/jech-2011-200341. Epub 2012 Jan 19.
6
Brazilian experience with rapid monitoring of vaccination coverage during a national rubella elimination campaign.巴西在全国风疹消除运动期间快速监测疫苗接种覆盖率的经验。
Rev Panam Salud Publica. 2011 Jul;30(1):7-14.
7
Survey of rubella knowledge and acceptability of rubella vaccination among Brazilian adults prior to mass vaccination.巴西成年人在大规模接种风疹疫苗前对风疹知识和接种意愿的调查。
Rev Panam Salud Publica. 2011 Oct;30(4):335-41.
8
The Brazilian health system: history, advances, and challenges.巴西卫生体系:历史、进展与挑战。
Lancet. 2011 May 21;377(9779):1778-97. doi: 10.1016/S0140-6736(11)60054-8. Epub 2011 May 9.
9
[Vaccination campaigns against poliomyelitis in Brazil (1960-1990)].[巴西针对脊髓灰质炎的疫苗接种运动(1960 - 1990年)]
Cien Saude Colet. 2011 Feb;16(2):501-11. doi: 10.1590/s1413-81232011000200013.
10
Outbreaks following wild poliovirus importations --- Europe, Africa, and Asia, January 2009-September 2010.野病毒输入引起的暴发疫情---欧洲、非洲和亚洲,2009 年 1 月至 2010 年 9 月。
MMWR Morb Mortal Wkly Rep. 2010 Nov 5;59(43):1393-9.